直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

European IP Blog

Cambodia - Europe’s New Frontier?

5 March 2018

Authored and Edited by Hazel Ford, Ph.D.; Leythem A. Wall

Since 1 March 2018, it has been possible to obtain patent protection in 44 countries across Europe and beyond into north Africa and southeast Asia, by filing a single patent application in the European Patent Office (EPO). 

In addition to the 38 countries that are member states of the European Patent Organisation, patent protection can be obtained in some additional countries by paying further official fees to the EPO at the same time as paying the EPO’s official designation fee, and then confirming the local registration of the patent in those countries after a patent has been granted by the EPO.

Between 1993 and 2009, the EPO entered into cooperation agreements with ten countries in the European region that were not EPO member states.  Most of those countries have since become full member states, but it is still possible to use these agreements to obtain protection in Montenegro and in Bosnia & Herzegovina.  These are referred to by the EPO as “extension states”. 

More recently, the EPO has entered into agreements with countries that are further afield, known as “validation states”.  In 2015 it became possible to validate a European patent in Morocco and in the Republic of Moldova.  In December 2017, Tunisia was added as a further validation state and, most recently, a validation agreement with Cambodia came into effect on 1 March 2018.  Under these agreements, it is possible to validate a European patent in these countries, where it will then confer essentially the same protection as a European patent would in one of the EPO’s member states.

It should be noted that it is not currently possible to use this EPO validation route to obtain patent protection in Cambodia for pharmaceutical products.  This is because pharmaceutical products are excluded from patent protection in Cambodia, as permitted under the World Trade Organisation (WTO) waiver for Least Developed Countries.  It is, however, still possible to file patent applications for pharmaceutical inventions in Cambodia: they will be put on hold until the waiver expires, currently expected to be in January 2033.  At that stage, protection in Cambodia may be granted for the remainder of the patent term, calculated from the filing date of the application.

Tags

European Patent Office (EPO)

Copyright © 2018 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information. 

Related Insights

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP